Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Godin

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 24, 2011
Uremic toxin indoxyl sulfate inhibits human vascular smooth muscle cell proliferationAnaïs Mozar, Loïc Louvet, Patrice Morlière, et al.
Biochemical and Biophysical Research Communications|December 17, 2011
Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditionsEric Trécherel, Corinne Godin, Christophe Louandre, et al.
Oncology Reports|December 21, 2018
Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinomaCorinne Godin, Sandra Bodeau, Zuzana Saidak, et al.
International Journal of Cancer|April 20, 2012
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenibZakaria Ezzoukhry, Christophe Louandre, Eric Trécherel, et al.
Bioscience Reports|August 31, 2019
ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastomaClaire Lailler, Christophe Louandre, Mony Chenda Morisse, et al.
Cancer Letters|December 3, 2014
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cellsChristophe Louandre, Ingrid Marcq, Hicham Bouhlal, et al.
Anticancer Research|April 9, 2013
Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragmentsCorinne Godin, Sebastien Dupont, Zakaria Ezzoukhry, et al.
Anticancer Research|March 10, 2015
Biomarkers of apoptosis and necrosis in patients with hepatocellular carcinoma treated with sorafenibCorinne Godin, Christophe Louandre, Sandra Bodeau, et al.
Molecular Pharmacology|June 30, 2010
Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptorAxelle Caudrillier, Anne-Sophie Hurtel-Lemaire, Alice Wattel, et al.
Oncotarget|March 2, 2018
Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cellsChloé Sauzay, Christophe Louandre, Sandra Bodeau, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 24, 2011
Uremic toxin indoxyl sulfate inhibits human vascular smooth muscle cell proliferationAnaïs Mozar, Loïc Louvet, Patrice Morlière, et al.
Biochemical and Biophysical Research Communications|December 17, 2011
Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditionsEric Trécherel, Corinne Godin, Christophe Louandre, et al.
Oncology Reports|December 21, 2018
Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinomaCorinne Godin, Sandra Bodeau, Zuzana Saidak, et al.
International Journal of Cancer|April 20, 2012
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenibZakaria Ezzoukhry, Christophe Louandre, Eric Trécherel, et al.
Bioscience Reports|August 31, 2019
ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastomaClaire Lailler, Christophe Louandre, Mony Chenda Morisse, et al.
Cancer Letters|December 3, 2014
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cellsChristophe Louandre, Ingrid Marcq, Hicham Bouhlal, et al.
Anticancer Research|April 9, 2013
Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragmentsCorinne Godin, Sebastien Dupont, Zakaria Ezzoukhry, et al.
Anticancer Research|March 10, 2015
Biomarkers of apoptosis and necrosis in patients with hepatocellular carcinoma treated with sorafenibCorinne Godin, Christophe Louandre, Sandra Bodeau, et al.
Molecular Pharmacology|June 30, 2010
Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptorAxelle Caudrillier, Anne-Sophie Hurtel-Lemaire, Alice Wattel, et al.
Oncotarget|March 2, 2018
Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cellsChloé Sauzay, Christophe Louandre, Sandra Bodeau, et al.
Pageof 3